Intro and Overview of Bispecifics in Non-Hodgkin Lymphoma (NHL)

Opinion
Video

Panelists discuss how bispecific antibodies are transforming the treatment landscape for non-Hodgkin lymphoma by enhancing T cell engagement and targeting malignant B cells effectively.

Video content above is prompted by the following:

Provide a brief overview of the use of bispecifics antibiotics (BsAbs) in NHL

  • Please give a brief overview of the four bispecific antibodies cuused in NHL
    • Mosunetuzumab
    • Epicortamab
    • Glofitamab
Related Content